| Product Code: ETC7550435 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Patient-derived Xenograft Model Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Patient-derived Xenograft Model Market Revenues & Volume, 2021 & 2031F |
3.3 India Patient-derived Xenograft Model Market - Industry Life Cycle |
3.4 India Patient-derived Xenograft Model Market - Porter's Five Forces |
3.5 India Patient-derived Xenograft Model Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.6 India Patient-derived Xenograft Model Market Revenues & Volume Share, By Model Type, 2021 & 2031F |
3.7 India Patient-derived Xenograft Model Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 India Patient-derived Xenograft Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Rising investments in healthcare research and development |
4.3 Market Restraints |
4.3.1 High cost associated with patient-derived xenograft models |
4.3.2 Limited availability of skilled professionals for conducting research using PDX models |
4.3.3 Stringent regulatory requirements for using animal models in research |
5 India Patient-derived Xenograft Model Market Trends |
6 India Patient-derived Xenograft Model Market, By Types |
6.1 India Patient-derived Xenograft Model Market, By Tumor Type |
6.1.1 Overview and Analysis |
6.1.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Tumor Type, 2021- 2031F |
6.1.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 India Patient-derived Xenograft Model Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 India Patient-derived Xenograft Model Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.6 India Patient-derived Xenograft Model Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 India Patient-derived Xenograft Model Market Revenues & Volume, By Other Cancer, 2021- 2031F |
6.2 India Patient-derived Xenograft Model Market, By Model Type |
6.2.1 Overview and Analysis |
6.2.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Mice, 2021- 2031F |
6.2.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Rats, 2021- 2031F |
6.3 India Patient-derived Xenograft Model Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F |
6.3.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.3.4 India Patient-derived Xenograft Model Market Revenues & Volume, By CROs & CDMOs, 2021- 2031F |
7 India Patient-derived Xenograft Model Market Import-Export Trade Statistics |
7.1 India Patient-derived Xenograft Model Market Export to Major Countries |
7.2 India Patient-derived Xenograft Model Market Imports from Major Countries |
8 India Patient-derived Xenograft Model Market Key Performance Indicators |
8.1 Average turnaround time for generating patient-derived xenograft models |
8.2 Number of collaborations between research institutions and pharmaceutical companies for PDX model research |
8.3 Percentage of successful drug screenings using PDX models |
8.4 Adoption rate of PDX models in preclinical research studies |
9 India Patient-derived Xenograft Model Market - Opportunity Assessment |
9.1 India Patient-derived Xenograft Model Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.2 India Patient-derived Xenograft Model Market Opportunity Assessment, By Model Type, 2021 & 2031F |
9.3 India Patient-derived Xenograft Model Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 India Patient-derived Xenograft Model Market - Competitive Landscape |
10.1 India Patient-derived Xenograft Model Market Revenue Share, By Companies, 2024 |
10.2 India Patient-derived Xenograft Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here